{"groups":[{"description":"MM-121: 12 mg/kg IV weekly in 4-week cycles Cetuximab: 400 mg/m2 IV one-time loading dose followed by 200 mg/m2 IV weekly maintenance doses","id":"FG000","title":"Part 1: Cohort 1"},{"description":"MM-121: 20 mg/kg IV QW Cetuximab: 400 mg/m2 loading dose followed by 200 mg/m2 maintenance IV QW","id":"FG001","title":"Part 1: Cohort 2a"},{"description":"MM-121: 12 mg/kg IV QW Cetuximab: 400 mg/m2 loading dose followed by 250 mg/m2 maintenance IV QW","id":"FG002","title":"Part 1: Cohort 2b"},{"description":"MM-121: 40 mg/kg loading dose followed by 20 mg/kg IV QW Cetuximab: 400 mg/m2 loading dose followed by 200 mg/m2 maintenance IV QW","id":"FG003","title":"Part 1: Cohort 3a"},{"description":"MM-121: 20 mg/kg IV QW Cetuximab: 400 mg/m2 loading dose followed by 250 mg/m2 maintenance IV QW","id":"FG004","title":"Part 1: Cohort 3b"},{"description":"MM-121: 40 mg/kg one time loading dose followed by 20 mg/kg IV QW Cetuximab: 400 mg/m2 one-time loading dose followed by 250 mg/m2 maintenance IV QW","id":"FG005","title":"Part 1: Cohort 4"},{"description":"MM-121: 40 mg/kg loading dose followed by 20 mg/kg IV QW Cetuximab: 400 mg/m2 loading dose followed by 250 mg/m2 maintenance IV QW","id":"FG006","title":"Part 1: Expansion Cohort"},{"description":"MM-121: 20 mg/kg IV QW\n\nCetuximab: 400 mg/m2 loading dose followed by 200 mg/m2 maintenance IV QW\n\nIrinotecan: 180 mg/m2 IV Q2W","id":"FG007","title":"Part 2: Cohort 1"},{"description":"MM-121: 40 mg/kg loading dose followed by 20 mg/kg IV QW\n\nCetuximab: 400 mg/m2 loading dose followed by 250 mg/m2 maintenance IV QW\n\nIrinotecan: 180 mg/m2 IV Q2W","id":"FG008","title":"Part 2: Cohort 2"},{"description":"MM-121: 20 mg/kg IV QW\n\nCetuximab: 400 mg/m2 loading dose followed by 250 mg/m2 maintenance IV QW\n\nIrinotecan: 180 mg/m2 IV Q2W","id":"FG009","title":"Part 2: Expansion Cohort"}],"periods":[{"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"8"},{"groupId":"FG001","numSubjects":"4"},{"groupId":"FG002","numSubjects":"3"},{"groupId":"FG003","numSubjects":"3"},{"groupId":"FG004","numSubjects":"4"},{"groupId":"FG005","numSubjects":"4"},{"groupId":"FG006","numSubjects":"8"},{"groupId":"FG007","numSubjects":"6"},{"groupId":"FG008","numSubjects":"4"},{"groupId":"FG009","numSubjects":"4"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"8"},{"groupId":"FG001","numSubjects":"4"},{"groupId":"FG002","numSubjects":"3"},{"groupId":"FG003","numSubjects":"3"},{"groupId":"FG004","numSubjects":"4"},{"groupId":"FG005","numSubjects":"4"},{"groupId":"FG006","numSubjects":"8"},{"groupId":"FG007","numSubjects":"6"},{"groupId":"FG008","numSubjects":"4"},{"groupId":"FG009","numSubjects":"4"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"0"},{"groupId":"FG006","numSubjects":"0"},{"groupId":"FG007","numSubjects":"0"},{"groupId":"FG008","numSubjects":"0"},{"groupId":"FG009","numSubjects":"0"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}